Global Enzyme Immunoassay Market Projected to Expand at 7.2% CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Enzyme Immunoassay Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The enzyme immunoassay market has demonstrated significant growth in recent years. It is anticipated to expand from $20.01 billion in 2024 to $21.50 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.4%. The historical development can be attributed to the escalating prevalence of infectious diseases, the expansion of blood screening initiatives, advancements in laboratory infrastructure, increased utilization in food safety testing, and the rising demand for veterinary diagnostics.

The enzyme immunoassay market is anticipated to experience substantial growth in the coming years, projected to reach $28.37 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.2%. This expansion during the forecast period is primarily attributed to government and NGO-led disease control initiatives, the increasing prevalence of autoimmune disease detection, the broader adoption of point-of-care testing, a rising demand for companion diagnostics in oncology, and an expanding geriatric population. Significant trends for the forecast period include technological advancements in microplate readers and reagents, the development of innovative diagnostic technologies, the creation of eco-friendly reagents, the integration of AI and automation into immunoassays, and strategic collaborations and partnerships.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

Which Drivers Are Shaping The Enzyme Immunoassay Industry’s Market Share?

The escalating prevalence of infectious illnesses is projected to fuel the expansion of the enzyme immunoassay market in the future. Infectious diseases are defined as ailments resulting from detrimental microorganisms, including bacteria, viruses, fungi, or parasites, capable of interpersonal transmission. The weight of infectious diseases is intensifying because antimicrobial resistance complicates the treatment of prevalent infections, leading to extended sickness, elevated healthcare expenditures, and a higher death rate. Enzyme immunoassays prove extremely valuable for diagnosing infectious diseases, given their capacity for sensitive and specific identification of antigens or antibodies within patient specimens, thereby facilitating prompt discovery, efficient oversight, and swift therapy for conditions like HIV, hepatitis, and influenza. For example, in April 2025, data from the Minnesota Department of Health, a US-based government agency, showed that the percentage of HIV cases among males aged 35 to 39 climbed from 10% in 2023 to 17% in 2024, signaling a significant rise in this demographic’s share of overall cases. Consequently, the escalating impact of infectious diseases is fostering the expansion of the enzyme immunoassay market.

What Are The Major Segment Types Covered In The Enzyme Immunoassay Market?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

What Long-Term Trends Will Shape The Future Growth Of The Enzyme Immunoassay Industry?

Leading companies active in the enzyme immunoassay market are prioritizing the introduction of innovative enzyme immunoassay (EIA) solutions, such as fully automated enzyme immunoassays, to elevate diagnostic precision, minimize manual errors, and enhance workflow efficiency in clinical laboratory environments. Fully automated enzyme immunoassays denote diagnostic systems that autonomously carry out the entire testing procedure, thereby improving speed, accuracy, and consistency in laboratory outcomes. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, unveiled the fully automated Lumipulse G GFAP assay for research use only (RUO), thus expanding its neuro-biomarker portfolio. This RUO chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) in human plasma and serum using the LUMIPULSE G platform and delivers results in just 35 minutes. It functions as an astrocytic biomarker implicated in conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further strengthens Fujirebio’s expanding neuro menu, which already encompasses NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a singular automated system.

Which Major Industry Participants Are Leading The Enzyme Immunoassay Market Growth?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Enzyme Immunoassay Market?

North America was the largest region in the enzyme immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Enzyme Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2025, By The Business Research Company

Immunoassay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Enzyme Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

In Vitro Diagnostics Enzymes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795